Low-density resin microsphere for human body implantation as well as preparation method and application of low-density resin microsphere

By controlling the temperature and treatment steps during the preparation of resin microspheres, the problems of excessive density of resin microspheres and carcinogenic residues are solved, and low-density and low-toxic resin microspheres are prepared, which improves the enrichment in tumor tissues Capability and security.

CN119019591APending Publication Date: 2024-11-26CHENGDU YUNKE PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411129066.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing resin microspheres used for human implantation are too high, resulting in the inability to evenly distribute to tumor tissue in the body, the target ratio is low, and the carcinogenic substances styrene and divinylbenzene are present during the preparation of sodium polystyrene sulfonate. Residue affects safety.

Method used

By controlling the temperature below 65°C during the sulfonation and swelling process, the particle size is prepared by controlling the temperature to be lower than 65°C, and the method of sulfonation and then swelling is adopted, combined with dispersant pretreatment, polymerization, purification, acid-base conversion and sieving and washing. 20μm to 40μm, low-density polystyrene sodium sulfonate resin microspheres reduce the residue of monomer raw materials such as styrene and divinylbenzene and reduce cytotoxicity.

Benefits of technology

The prepared low-density resin microspheres have a density closer to blood density, which improves the enrichment ability in tumor tissue, reduces lung shunts, improves safety, and reduces the toxicity of microspheres through strict treatment steps, suitable as drug carriers or nuclei Marker.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019591A_ABST
    Figure CN119019591A_ABST
Patent Text Reader

Abstract

The invention discloses low-density resin microspheres for human body implantation and a preparation method and application thereof, and relates to the technical field of resin microspheres, the resin microspheres comprise sodium polystyrenesulfonate resin microspheres, and after a dispersing agent, styrene, divinyl benzene and an initiator are subjected to a polymerization reaction, the low-density resin microspheres are prepared. Sequentially carrying out purification, sulfonation, swelling and acid-base conversion to obtain sodium polystyrenesulfonate resin microspheres; wherein the reaction temperature in the sulfonation and swelling processes is lower than 65 DEG C. The resin microspheres prepared by the preparation method are low in density and can be implanted into a human body after being applied to nuclide labeling, animal experiments find that the density of the resin microspheres is closer to the density of blood, enrichment of the resin microspheres in tumor tissues can be improved, the target-to-cost ratio can be increased, lung shunt can be reduced, and therefore safety is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of resin microspheres, and in particular to low-density resin microspheres for human body implantation, and a preparation method and application thereof. Background Art

[0002] At present, the microspheres that can be used for human implantation mainly include glass microspheres and resin microspheres. The materials of resin microspheres are varied, mainly polystyrene resin, urea-formaldehyde resin, phenol-formaldehyde resin, polymethylsilsesquioxane resin, etc., among which polystyrene resin is the most widely used.

[0003] The commonly used polystyrene resin is sodium polystyrene sulfonate cation exchange resin, which is prepared mainly through suspension polymerization of styrene-divinylbenzene and then sulfonation. In the preparation method of sodium polystyrene sulfonate, the temperature of polystyrene sulfonation reaction is generally 80℃~110℃. The higher the degree of sulfonation, the higher the density of the obtained resin microspheres. 3 ) resin microspheres are prepared into radioactive drugs. However, due to the high density and fast sedimentation rate of the microspheres, they cannot be evenly distributed in the tumor tissue in the body, the target-to-substance ratio is low, and when the reaction temperature reaches 80°C to 110°C, the color of sodium polystyrene sulfonate is dark, and acetone or methanol needs to be added for soaking and drifting in the post-processing, which is cumbersome.

[0004] In addition, the carcinogenicity data released by the World Health Organization's International Agency for Research on Cancer lists styrene as a carcinogen, which is harmful to the eyes, respiratory system, nervous system, reproductive system, etc. Divinylbenzene can enter the human body through skin absorption, and inhalation can cause coughing, dry throat, redness, swelling and pain on the skin and eyes. It has an inhibitory effect on the central nervous system, causing nausea, fatigue, headache, dizziness and loss of consciousness. Long-term contact can cause pulmonary edema. Therefore, the residues of styrene and divinylbenzene in medical-grade sodium polystyrene sulfonate resin microspheres must be strictly controlled. Summary of the invention

[0005] Based on the problem that the density of resin microspheres implanted in the human body is too high, the purpose of the present invention is to provide a low-density resin microsphere for human body implantation and a preparation method and application thereof. The resin microspheres prepared by the preparation method have a low density and can be implanted in the human body after being applied to radionuclide labeling. Animal experiments have found that their density is closer to the density of blood, which can increase the enrichment of resin microspheres in tumor tissues, improve the target-to-species ratio, reduce pulmonary shunt, and thus improve safety.

[0006] The present invention is achieved through the following technical solutions:

[0007] In a first aspect, the present application provides a method for preparing low-density resin microspheres for human implantation, wherein the resin microspheres include sodium polystyrene sulfonate resin microspheres, which are polymerized using a dispersant, styrene, divinylbenzene and an initiator, and then purified, sulfonated, swollen and acid-base converted in sequence to obtain sodium polystyrene sulfonate resin microspheres; wherein the reaction temperature during the sulfonation and swelling process is lower than 65°C.

[0008] The preparation method of the resin microspheres can obtain polystyrene sodium sulfonate resin microspheres with a particle size of 20 μm to 40 μm, low density and low irritation after being processed by dispersant pretreatment, polymerization reaction, purification process, sulfonation reaction, swelling process, acid-base conversion process, and screening and washing process. The purification process can effectively reduce the residual organic solvents of monomer raw materials such as styrene and divinylbenzene in the resin microspheres, and can control the styrene content to be less than 1 ppm, divinylbenzene to be less than 5 ppm, heavy metal content to be less than 10 ppm, arsenic salt content to be less than 1 ppm, less impurity residues, and low bacterial endotoxin, which is less than 15 EU / mL, and can be directly used as a drug carrier or marker without further treatment, which helps to reduce cytotoxicity and improve safety.

[0009] In addition, the temperature of the sulfonation and swelling process is controlled below 65°C, which can make the density of the prepared sodium polystyrene sulfonate resin microspheres 1.05 g / cm 3 ~1.35g / cm 3 The low-density sodium polystyrene sulfonate resin microspheres can be implanted in the human body after radionuclide labeling, and the density is closer to the density of blood, which can increase the enrichment of microspheres in tumor tissues, improve the target-to-substance ratio, reduce pulmonary shunt, and thus improve safety.

[0010] Furthermore, the preparation method of the sodium polystyrene sulfonate resin microspheres comprises the following steps:

[0011] Dispersant pretreatment: dissolving the dispersant in water to obtain an initial dispersant solution;

[0012] Polymerization reaction: After the dispersant solution is heated and stabilized, styrene, divinylbenzene and initiator are added, heated to react under stirring, and then heated again. After the reaction is completed, pure water is used for immersion and precipitation, and polystyrene resin microspheres are obtained after washing;

[0013] Purification process: using a cleaning agent to clean the polystyrene resin microspheres, and drying after cleaning to obtain purified polystyrene resin microspheres;

[0014] Sulfonation reaction: adding a sulfonating agent to the purified polystyrene resin microspheres, stirring and reacting, to obtain sulfonated polystyrene resin microspheres;

[0015] Swelling process: adding a swelling agent to the sulfonated polystyrene resin microspheres, stirring the reaction and then standing, and then heating and swelling, increasing the temperature and swelling again in sequence;

[0016] Acid-base conversion process: add sodium hydroxide solution to the sulfonated polystyrene resin microspheres obtained after swelling, filter after soaking, then wash with water until neutral, then transfer to hydrochloric acid solution for soaking, then filter again, and wash with water until neutral; repeat the above operation; then add sodium hydroxide solution to the sulfonated polystyrene resin microspheres, soak, filter and wash with water until neutral to obtain sodium polystyrene sulfonate resin microspheres.

[0017] In the above technical scheme, the dispersant is firstly fully dissolved in water, which improves the solubility of the dispersant in water, facilitates the subsequent addition of styrene, divinylbenzene and initiator, and dispersant to fully contact, and then reacts at low temperature to obtain a particle size uniform, stable performance, and density of 1.05-1.35 g / cm 3 Sodium polystyrene sulfonate resin microspheres.

[0018] During the polymerization reaction, the dispersant is evenly dispersed in the water, and then at a suitable rotation speed, it is more conducive to the polymerization reaction of styrene and divinylbenzene. The method of first sulfonation and then swelling is adopted, and at a relatively low temperature, the pores of the polystyrene resin microspheres can be expanded, so that the sulfonic acid groups are evenly distributed on the microspheres, and then low-sulfonation-degree, low-density polystyrene sodium sulfonate resin microspheres are obtained by low-temperature synthesis.

[0019] Among them, the sodium polystyrene sulfonate resin microspheres after the acid-base conversion process are crude products. To obtain fine products, they can be screened and washed with water.

[0020] The screening and washing method is as follows: adding pure water to the polystyrene sulfonate sodium resin microspheres after acid-base conversion treatment to soak, then screening the polystyrene sulfonate sodium resin microspheres with an oscillating screening instrument, and then washing the polystyrene sulfonate sodium resin microspheres with injection water to obtain the finished resin microspheres.

[0021] The particle size of the sodium polystyrene sulfonate resin microspheres obtained after sieving with the vibration sieving instrument is 20 μm to 40 μm. The amount of water for injection is 5 to 10 times that of the sodium polystyrene sulfonate resin microspheres, and the washing times are three times.

[0022] After the obtained sodium polystyrene sulfonate resin microspheres are subjected to acid-base conversion and screening and water washing treatment, the sodium type and hydrogen type are transformed into each other, and the sodium polystyrene sulfonate resin microspheres are more stable. The screening process selects resin microspheres with a particle size of 20μm to 40μm and low irritation, which can be directly used as drug carriers or labels without further treatment.

[0023] Furthermore, the dispersant includes any one or more combinations of hydroxyethyl cellulose, polyvinyl alcohol, methyl cellulose, sodium dodecylbenzene sulfonate, and polypropylene alcohol.

[0024] Furthermore, the initiator includes any one or more combinations of azobisisobutyronitrile, methyl ethyl ketone peroxide, benzoyl peroxide, and cumene peroxide.

[0025] Furthermore, the cleaning agent includes any one or more combinations of acetone, n-butanol, and ethanol.

[0026] Furthermore, the sulfonating agent includes any one or more combinations of sulfur trioxide, concentrated sulfuric acid, and sulfites, preferably concentrated sulfuric acid.

[0027] Furthermore, the swelling agent includes any one or more combinations of trichloroethane, dichloromethane, toluene, n-heptane, n-pentane, and n-propanol, preferably dichloromethane or n-propanol, and more preferably n-propanol with low toxicity.

[0028] Furthermore, when the dispersant is dissolved, it is stirred and dissolved at a stirring speed of 200 rpm to 500 rpm.

[0029] Furthermore, during the purification treatment, after the addition of washing, the treatment is carried out by condensation reflux for 6h to 8h, and the reaction temperature is 65°C to 75°C.

[0030] Furthermore, during the sulfonation reaction, the reaction time is controlled within 2 h to 3 h after the sulfonating agent is added.

[0031] Furthermore, during the swelling reaction, after the swelling agent is added, the swelling time is controlled within 3 h to 4 h.

[0032] Furthermore, during the acid-base conversion treatment, the concentration of the added sodium hydroxide is 1.0 mol / L to 1.5 mol / L, and the concentration of the hydrochloric acid is 1.0 mol / L to 2.0 mol / L.

[0033] Furthermore, during the polymerization reaction, the temperature is first heated to 25°C to 55°C, and then raised to 85°C to 95°C.

[0034] Furthermore, in the swelling reaction, the temperature for heating and swelling is 25°C to 50°C, the temperature for heating and swelling is 55°C to 60°C, and the temperature for further heating and swelling is 60°C to 65°C.

[0035] In a second aspect, the present application provides a low-density resin microsphere for human body implantation, wherein the resin microsphere is a resin microsphere prepared by the above-mentioned preparation method.

[0036] In a third aspect, the present application provides an application of resin microspheres prepared by the above method for human body implantation, including for radionuclide labeling.

[0037] Furthermore, the nuclides of the nuclide-labeled resin microspheres include one or more of yttrium, lutetium, iodine, indium, phosphorus, rhenium or iridium, preferably yttrium [ 90 Y].

[0038] Among them, the yttrium marker [ 90 Y] solution selected yttrium chloride [ 90 Y] solution or yttrium sulfate [ 90 Y] solution.

[0039] Sodium polystyrene sulfonate resin microspheres were treated with yttrium[ 90 Y] labeled with yttrium [ 90 Y] resin microspheres have obvious adsorption strength, and the safety is significantly improved in the entire labeling preparation process. 90 Y] Resin microspheres are significantly enriched in tumor tissues, with a high target-to-substance ratio.

[0040] Furthermore, the labeling method is: evenly stirring the radionuclide labeling solution with determined activity and sodium polystyrene sulfonate resin microspheres, loading the reaction, and washing to obtain radioactively labeled resin microspheres.

[0041] Furthermore, the temperature of the loading reaction is 25°C to 50°C.

[0042] Compared with the prior art, the present invention has the following advantages and beneficial effects:

[0043] (1) In the preparation method of the present invention, the reaction temperature is controlled to be lower than 65°C during the entire sulfonation and swelling process. Compared with the conventional technical scheme, the present invention adopts the method of first sulfonation, then swelling, and finally heating. The density of the synthesized resin microspheres is 1.05g / cm 3 ~1.35g / cm 3 The resin microspheres can be implanted in the human body after being labeled with radionuclides, and the density is closer to that of blood, which can further increase the enrichment of the resin microspheres in tumor tissues, improve the target-to-substance ratio, and reduce pulmonary shunt, thereby improving safety.

[0044] (2) In the acid-base conversion process of the present invention, the sodium hydroxide solution and the hydrochloric acid solution are alternately immersed in the conversion washing and screening washing process, which can reduce the residual excess raw materials and organic solvents. The residual styrene flow is less than 1ppm, the divinylbenzene residual amount is less than 5ppm, the heavy metal content is less than 10ppm, and the arsenic salt content is less than 1ppm, thereby reducing the toxicity of the prepared resin microspheres themselves;

[0045] (3) The acid-base conversion process and the screening and washing process of the present invention use injection water for washing, which can fully wash the toxins inside the resin. The resin microspheres have low bacterial endotoxins and can be directly applied to yttrium[ 90Y] labeled to obtain yttrium [ 90 Y] Resin microspheres. BRIEF DESCRIPTION OF THE DRAWINGS

[0046] In order to more clearly illustrate the technical solutions of the exemplary embodiments of the present invention, the following briefly introduces the drawings required for use in the embodiments. It should be understood that the following drawings only illustrate certain embodiments of the present invention and should not be regarded as limiting the scope. For those of ordinary skill in the art, other relevant drawings can be obtained based on these drawings without creative work. In the drawings:

[0047] Figure 1 is an infrared spectrum of sodium polystyrene sulfonate resin microspheres prepared in Example 1 of the present invention;

[0048] Figure 2 Graph showing the test results of the styrene content in the sodium polystyrene sulfonate resin microspheres prepared in Example 1 of the present invention;

[0049] Figure 3 is a particle size distribution diagram of sodium polystyrene sulfonate resin microspheres prepared in Example 1 of the present invention;

[0050] Figure 4 This is the relationship between microsphere density and synthesis temperature. DETAILED DESCRIPTION

[0051] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments.

[0052] Therefore, the following detailed description of the embodiments of the present invention provided in the accompanying drawings is not intended to limit the scope of the invention claimed for protection, but merely represents selected embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0053] Example 1

[0054] This embodiment provides a method for preparing sodium polystyrene sulfonate resin microspheres, which is prepared according to the following steps:

[0055] S1. Dispersant pretreatment: 10 g of polyvinyl alcohol was added to 1000 mL of water, and stirred at a stirring speed of 500 rpm for 6 hours to dissolve the dispersant in the water to obtain an initial dispersant solution.

[0056] S2, polymerization reaction: the initial dispersant solution obtained in step S1 is heated to 50°C. After the temperature stabilizes, 100 mL of styrene, 20 mL of divinylbenzene and 10 g of benzoyl peroxide are added, stirred at a stirring rate of 700 rpm, reacted at 50°C for 2 hours, then heated to 90°C for 5 hours. After the reaction is completed, the solution is immersed in pure water for sedimentation and washed to obtain polystyrene resin microspheres.

[0057] S3, purification process: adding the polystyrene resin microspheres prepared in step S2 into a Soxhlet extractor, adding 100 mL of acetone, condensing and refluxing, taking out and drying, to obtain purified polystyrene resin microspheres.

[0058] S4, sulfonation process: add 100 mL of concentrated sulfuric acid to the polystyrene resin microspheres in step S3, and stir to react.

[0059] S5, swelling process: add 100 mL of n-propanol to the polystyrene resin microspheres in step S4, stir the reaction at a stirring rate of 300 rpm and let it stand, then heat and swell at 40° C. for 2 hours, then heat to 55° C. for 2 hours, and finally heat to 60° C. for 5 hours.

[0060] S6, acid-base conversion process: add 1.5 mol / L sodium hydroxide solution to the sulfonated polystyrene resin microspheres obtained in step S5, and then soak, filter, and wash with water until neutral, and then transfer to 2.0 mol / L hydrochloric acid solution to soak, filter, and wash with water until neutral; repeat the above operation once, and then add 1.5 mol / L sodium hydroxide solution to the sulfonated polystyrene resin microspheres, soak for 16 hours, and then filter and wash with water until neutral to obtain crude polystyrene sodium sulfonate resin microspheres.

[0061] S7, screening and washing process: pure water is added to the crude polystyrene sulfonate resin microspheres obtained in step S6, and then the polystyrene sulfonate resin microspheres are screened using an oscillating screening instrument, and then the polystyrene sulfonate resin microspheres are washed three times with 500 mL of injection water to obtain finished resin microspheres, which are light yellow microspheres.

[0062] Example 2

[0063] This embodiment provides a method for preparing sodium polystyrene sulfonate resin microspheres, which is different from that of embodiment 1 in that:

[0064] S1. Dispersion pretreatment: 10 g of hydroxyethyl cellulose was added to 1000 mL of water, and stirred at a stirring speed of 500 rpm for 6 hours to dissolve the dispersant in the water to obtain an initial dispersant solution.

[0065] The other steps are the same as those in Example 1.

[0066] Example 3

[0067] This embodiment provides a method for preparing sodium polystyrene sulfonate resin microspheres, which is different from that of embodiment 1 in that:

[0068] S1. Dispersion pretreatment: 8 g of polyvinyl alcohol and 2 g of hydroxyethyl cellulose were added to 1000 mL of water, and stirred at a stirring speed of 500 rpm for 6 hours to dissolve the dispersant in the water to obtain an initial dispersant solution.

[0069] The other steps are the same as those in Example 1.

[0070] Example 4

[0071] This embodiment provides a method for preparing sodium polystyrene sulfonate resin microspheres, which is different from that of embodiment 1 in that:

[0072] S2, polymerization reaction: the dispersant solution obtained in step S1 is heated to 50°C, 100 mL of styrene, 20 mL of divinylbenzene and 10 g of azobisisobutyronitrile are added after the temperature stabilizes, and the mixture is heated to react for 2 hours at a stirring rate of 700 rpm, and then the mixture is heated to 90°C and reacted for 5 hours. After the reaction is completed, the mixture is immersed in pure water for sedimentation, and the polystyrene resin microspheres are obtained after washing.

[0073] The other steps are the same as those in Example 1.

[0074] Example 5

[0075] This embodiment provides a method for preparing sodium polystyrene sulfonate resin microspheres, which is different from that of embodiment 1 in that:

[0076] S2, polymerization reaction: the dispersant solution obtained in step S1 is heated to 50°C, 80 mL of styrene, 40 mL of divinylbenzene and 10 g of benzoyl peroxide are added after the temperature stabilizes, and the mixture is heated to react for 2 hours at a stirring rate of 700 rpm, and then the temperature is raised to 90°C for reaction for 5 hours. After the reaction is completed, the mixture is immersed in pure water for precipitation, and the polystyrene resin microspheres are obtained after washing.

[0077] The other steps are the same as those in Example 1.

[0078] Example 6

[0079] This embodiment provides a method for preparing sodium polystyrene sulfonate resin microspheres, which is different from that of embodiment 1 in that:

[0080] S3, purification process: adding the polystyrene resin microspheres prepared in step S2 into a Soxhlet extractor, adding 100 mL of n-butanol, condensing and refluxing, taking out and drying, to obtain purified polystyrene resin microspheres.

[0081] The other steps are the same as those in Example 1.

[0082] Example 7

[0083] This embodiment provides a method for preparing sodium polystyrene sulfonate resin microspheres, which is different from that of embodiment 1 in that:

[0084] S5, swelling process: add 100 mL of dichloromethane to the sulfonated polystyrene resin microspheres obtained in step S4, stir the reaction and let it stand, then add it to swell for 2 hours at a temperature of 40° C., heat it to 55° C. and swell for another 2 hours, and then heat it to 60° C. and swell for 5 hours.

[0085] The other steps are the same as those in Example 1.

[0086] Example 8

[0087] This embodiment provides a yttrium [ 90 Y] resin microsphere preparation method, first use the method of step S1 to step S7 in Example 1 to prepare sodium polystyrene sulfonate resin microspheres, then add yttrium chloride [ 90 Y] solution and 2g of sodium polystyrene sulfonate resin microspheres were stirred evenly, stirred and reacted at 37°C for 2h, and washed with 10ml of injection water to obtain yttrium [ 90 Y] Resin microspheres.

[0088] Comparative Example 1

[0089] This comparative example provides a method for preparing sodium polystyrene sulfonate in the prior art, which is prepared according to the following steps:

[0090] S1. Dispersant dispersion: add 10 g of gelatin into 280 g of water, heat to 75°C, disperse for 18 min, and then cool the entire reaction solution to 25°C to obtain an initial dispersion.

[0091] S2, polymerization reaction: at a stirring speed of 1100r / min, 50g of styrene, 15g of divinylbenzene and 1.5g of benzoyl peroxide were added to the initial dispersion obtained in step S1, and the mixture was stirred at a temperature of 30°C for 1 hour, then the temperature was raised to 70°C within 20min, and maintained for 3 hours, then the temperature was raised to 85°C within 1 hour, and maintained for 2 hours, then the temperature was raised to 90°C within 10min, and maintained for 1 hour. After completion of the reaction, the product was washed with 90°C hot water of 4 times the volume of the reaction solution, centrifuged, and dried at a temperature of 100°C to obtain polystyrene resin microspheres, which were white.

[0092] S3, swelling process: add 10 g of polystyrene resin microspheres obtained in step S2 into 50 g of dichloromethane and stir for 28 min to obtain a swelling solution.

[0093] S4, sulfonation reaction: add 32g of concentrated sulfuric acid to the swelling solution obtained in step S3, react at 85°C for 6 hours at a stirring speed of 100r / min, and then heat to 95°C for 2 hours. After the reaction is completed, wash with water until neutral to obtain sulfonated polystyrene resin microspheres, which are yellow microspheres.

[0094] S5. Ion exchange reaction: add a 13 mol / L sodium hydroxide solution to the sulfonated polystyrene resin microspheres obtained in step S4 until the pH is maintained at 10-12 for 30 min. Stir at 45° C. and 200 r / min for 7 hours. After the reaction, filter the mixture and wash with water until it is neutral to obtain a crude product.

[0095] S6, washing process: add 200 mL of water to the crude product obtained in step S5, stir evenly, let stand for 10 min, pour out the upper liquid, repeat the washing step until the supernatant solution becomes clear, dry the solid in the lower solution at 110° C. for 5 hours to obtain sodium polystyrene sulfonate as light yellow microspheres.

[0096] Comparative Example 2

[0097] This comparative example provides a commercially available BIO-RAD Aminex 50W-X4 cation exchange resin for comparison with the resin microspheres prepared in Example 1.

[0098] Comparative Example 3

[0099] This comparative example provides a method for preparing sodium polystyrene sulfonate resin microspheres. The difference from Example 1 is that step S5 and step S6 are different. Step S5 and step S6 in this comparative example are as follows:

[0100] S5, ion exchange process: adding 1.5 mol / L sodium hydroxide solution to the sulfonated polystyrene resin microspheres obtained in step S4, and then soaking, filtering, and washing with water until neutral to obtain sodium polystyrene sulfonate resin microspheres.

[0101] S6, screening and washing process: the crude sodium polystyrene sulfonate resin microspheres in step S5 are added into pure water for soaking, and then the sodium polystyrene sulfonate resin microspheres are screened by an oscillating screening instrument to obtain finished resin microspheres, which are light yellow microspheres.

[0102] Comparative Example 4

[0103] This comparative example provides a method for preparing sodium polystyrene sulfonate resin microspheres. Different from Example 1, step S5 in this comparative example is as follows:

[0104] S5, swelling process: add 100 mL of n-propanol to the sulfonated polystyrene resin microspheres obtained in step S4, stir the reaction at 300 rpm and let stand, then heat at 40° C. to swell for 2 hours, then heat to 55° C. to swell for 2 hours, and then heat to 70° C. to swell for 5 hours.

[0105] Comparative Example 5

[0106] This comparative example provides a method for preparing sodium polystyrene sulfonate resin microspheres. Different from Example 1, step S5 in this comparative example is as follows:

[0107] S5, swelling process: add 100 mL of n-propanol to the sulfonated polystyrene resin microspheres obtained in step S4, stir the reaction at 300 rpm and let stand, then heat to 40° C. for swelling for 2 hours, then heat to 55° C. for swelling for 2 hours, and then heat to 80° C. for swelling for 5 hours.

[0108] Comparative Example 6

[0109] This comparative example provides a method for preparing sodium polystyrene sulfonate resin microspheres. Different from Example 1, step S5 in this comparative example is as follows:

[0110] S5, swelling process: add 100 mL of n-propanol to the sulfonated polystyrene resin microspheres obtained in step S4, stir the reaction at 300 rpm and let stand, then heat to 40° C. for swelling for 2 hours, then heat to 55° C. for swelling for 2 hours, and then heat to 90° C. for swelling for 5 hours.

[0111] Test Example 1: Performance Testing

[0112] The resin microspheres are tested for infrared spectra, particle size range, and density (g / cm 3 ), styrene content (ppm), divinylbenzene content (ppm), heavy metal content (ppm), arsenic salt content (ppm), bacterial endotoxin (EU / mL, each mL of solution contains 0.2g of resin microspheres):

[0113] (1) The infrared spectrum of the sodium polystyrene sulfonate resin microspheres synthesized in Example 1 is shown in the attached figure. Figure 1 As shown (KBr tablet method).

[0114] Figure 1 The spectrum of the sample was compared with the standard spectrum of sodium polystyrene sulfonate resin microspheres. -1 Residual moisture of the sample, 2920cm -1 -CH2- vibration peak, 2000~1600cm -1It is the double frequency and combined frequency peak of H atoms on the benzene ring, 1640cm -1 -C=C- stretching vibration. If this peak disappears completely, it indicates that styrene and divinylbenzene are completely polymerized. 1650~1500cm -1 Benzene ring skeleton vibration peak, 1200~1100cm -1 It is a strong antisymmetric / symmetric stretching vibration absorption peak of the sulfonic acid group S=O, indicating that it contains sulfonic acid groups, which is consistent with the standard spectrum.

[0115] (2) Styrene detection adopts the European Pharmacopoeia method: UPLC (single point method) detection, specific method: chromatographic column: size = 0.25m, Stationary phase: octadecyl silica gel R (5 μm). Mobile phase: acetonitrile, water (1:1 V / V). Flow rate: 1.5 mL / min. Detection: spectrophotometer, 254 nm. Injection volume: 20 μL.

[0116] The content of styrene in the sodium polystyrene sulfonate resin microspheres synthesized in Example 1 is as shown in the attached Figure 2 As shown, the specific styrene content of other embodiments and comparative examples is shown in Table 1 and Table 2. The styrene content in the sodium polystyrene sulfonate resin microspheres synthesized in the embodiments is less than 1 ppm.

[0117] (3) The density, styrene content, divinylbenzene content, heavy metal content, arsenic salt content, and bacterial endotoxin content of the resin microspheres prepared in Examples 1 to 7 and Comparative Examples 1 to 3 were tested. The test results are shown in Table 1 below.

[0118] Table 1

[0119]

[0120] It can be seen from Table 1 that by using the method provided by the present invention, the density of the resin microspheres in Examples 1 to 7 is controlled to be between 1.09 and 1.25 g / cm 3, during the synthesis process of the entire resin microsphere, less toxic reagents such as acetone and n-propanol are selected to synthesize qualified resin microspheres of pharmaceutical grade. The obtained finished resin microspheres were tested and found to have a styrene content of less than 1.0ppm, a divinylbenzene content of less than 2.0ppm, an arsenic salt content of less than 1ppm, and a bacterial endotoxin content of less than 10EU / mL. In addition, Comparative Examples 1 and 2 did not pay attention to the residual content of styrene and divinylbenzene. Through detection, it was found that the styrene content was higher than 1ppm, the divinylbenzene content was higher than 5ppm, and the bacterial endotoxin was higher than 10EU / mL. The use of the preparation required to reduce the residual content of styrene in the resin. Compared with Comparative Example 3, it was found that the acid-base conversion process was beneficial to reducing the styrene content in the resin microspheres. Using the method provided by the present invention, the toxicity and irritant substances of the resin microspheres are strictly controlled, and the obtained resin microspheres are less irritating and less toxic, and can be directly used in preparations or markings without further processing.

[0121] (4) Detection of particle size distribution of resin microspheres

[0122] The particle size of the resin microspheres synthesized in the examples and comparative examples was obtained by testing with an XDS-1B particle size analyzer. The testing method is as follows: use a dropper to draw an appropriate amount of blank water from three different positions: upper, middle, and lower, and drop them on different positions on a glass slide. Place the glass slide on the stage of a microscope, use an eyepiece (X10) and an objective lens (X25), and operate according to the "Standard Operating Procedures for XDS-1B Particle Size Analyzer". Randomly select three fields of view, test three times, and obtain the number of particles and particle size. The sodium polystyrene sulfonate resin microspheres of Examples 1 to 7 can be screened to control the particle size of the resin microspheres to be within the range of 20 to 40 μm. The particle size distribution of the sodium polystyrene sulfonate resin microspheres in Example 1 is shown in the attached figure. Figure 3 shown.

[0123] (5) Verify the effect of resin microsphere synthesis temperature on resin microsphere density, styrene content, divinylbenzene content, heavy metal content, arsenic salt content, and bacterial endotoxin content. The test results are shown in Table 2.

[0124] Table 2

[0125]

[0126] As can be seen from Table 2, compared with Comparative Example 1, the sulfonation synthesis temperature of 60° C. during the synthesis of the resin microspheres using the method provided by the present invention (Example 1) is low, and the simultaneous sulfonation process and the swelling process make the sulfonation degree of the resin microspheres relatively low, and the density of the obtained resin microspheres is closer to the low-density resin microspheres of blood, such as Figure 4The graph shows the relationship between the density of the microspheres and the synthesis temperature. It can be seen from Example 1 and Comparative Example 1 and Comparative Examples 4 to 6 that, when other conditions of the preparation method remain unchanged, as the synthesis temperature increases, the degree of sulfonation of the resin microspheres increases and the density is higher. However, the density of the resin microspheres prepared in Comparative Examples 1 and Comparative Examples 4 to 6 is too high, and it was found that the enrichment effect was poor when applied to in vivo experiments. The resin microspheres prepared at a synthesis temperature of 60°C in Example 1 of the present application are more suitable for human implantation.

[0127] Experimental Example 2: Comparison of the in vitro cytotoxicity of the resin microspheres prepared by the method of the present invention and the microsphere products of the prior art.

[0128] 1. Sample Preparation

[0129] 1.1 Preparation of test samples

[0130] 0.2 g samples of Example 1, Example 2 and Example 3 were prepared respectively and processed as follows:

[0131] Pre-saturate the sample in 5 mL of cell culture medium at 37°C (or (37±1)°C) for 24 hours (or 24±2 hours). Take out the pre-saturated sample, take an appropriate amount of the test sample in the cell culture medium at a ratio of 0.2 g / mL, and prepare the test solution by shaking and extracting at 60 rpm for 24 hours (or 24±2 hours) at 37°C (or (37±1)°C).

[0132] 1.2 Comparative Example Preparation

[0133] Comparative Examples 1, 2 and 3 all prepared the test solutions according to the treatment method of the test sample group.

[0134] 1.3 Positive Control

[0135] 10% DMSO solution, freshly prepared for use.

[0136] 1.4 Negative Control

[0137] High density polyethylene. According to 6cm 2 The negative control was added with 1 mL of cell culture medium and extracted at 37°C (or (37±1)°C) at 60 rpm for 24 hours (or 24±2 hours).

[0138] 1.5 Blank control

[0139] The cell culture medium without test samples was treated in the same way as the test sample group.

[0140] 2. Experimental Methods

[0141] Take the well-grown L929 cells and prepare a cell suspension with a cell culture medium, adjust the density to 1×105 cells / ml, inoculate it in a 96-well plate, add 100 μL / well cell suspension, place it in a cell culture incubator (5% CO2, 37°C) and incubate for 24 hours to form a nearly confluent monolayer of cells. Check each well plate under a microscope to ensure that the cell growth in each well plate is relatively equal, aspirate the original culture medium, add 100 μL of the test solution (Example 1, Example 2, Example 3), the comparative solution (Comparative Example 1, Comparative Example 2, Comparative Example 3), the positive control solution, the negative control solution and the blank control solution to each well. Place it in a cell culture incubator and culture it for 24 hours, and observe the cell morphology of each well plate under a microscope. Carefully remove the culture medium, add 50 μL of MTT solution to each well, continue to culture in the cell culture incubator for 2 hours, then discard the solution in the wells, add 100 μL of isopropanol to each well, shake the plate, and measure the absorbance at a wavelength of 570 nm (reference wavelength 650 nm) with an ELISA reader. Calculate the survival rate (%) as follows:

[0142] Survival rate (%) = OD570e / OD570b × 100%. Wherein: OD570e refers to the absorbance of the test group, comparative group, negative control group, and positive control group; OD570b refers to the absorbance of the blank control group. According to the toxicity evaluation standard in the 2017 version of GB / T 16886.5, if the survival rate is greater than 70%, it is considered to be non-cytotoxic.

[0143] 3. Experimental results

[0144] From the perspective of cell morphology, the cells in the test sample (Examples 1, 2, and 3) groups grew well, with a small number of cells showing rounded, loosely attached to the wall, no intracytoplasmic particles, and occasional cell lysis; in the comparative example (Comparative Example 1, 2, and 3) groups, some cells showed rounded, loosely attached to the wall, no intracytoplasmic particles, and some cells showed lysis. The results of the 24h MTT assay are shown in Table 3 below.

[0145] Table 3

[0146]

[0147]

[0148] From the results, the cell survival rates of Examples 1, 2 and 3 are relatively high compared with Comparative Examples 1, 2 and 3. Studies have shown that reducing the residual monomer raw materials such as styrene and divinylbenzene in the resin microspheres helps to reduce cytotoxicity and improve safety.

[0149] Test Example 3: Comparison of the tissue distribution of the resin microspheres prepared by the method of the present invention and the microsphere products of the prior art in rats.

[0150] 1. Sample Preparation

[0151] 1.1 Preparation of test samples

[0152] Prepare yttrium according to Example 8 [ 90 Y] Resin microspheres.

[0153] 1.2 Comparative Example Preparation

[0154] The microspheres of Comparative Example 1, Comparative Example 2 and Comparative Example 6 were prepared according to the method of Example 8. 90 Y-labeled radioactive microspheres were used to obtain radioactive comparative example 1, radioactive comparative example 2, and radioactive comparative example 6.

[0155] 2. Experimental Methods

[0156] 2.1 Establishment of rat liver cancer model

[0157] 12 rats (SPF grade, male, 350-400g) were weighed, anesthetized with 3% pentobarbital intraperitoneally, depilated and disinfected. The rats underwent a 1.5-2cm long subxiphoid laparotomy to expose the left and right lobes of the liver. Using a 27-gauge needle, the S1N1 cell suspension was slowly injected into one of the liver lobes under the liver capsule, forming an approximately circular transparent bulge visible to the naked eye. The location of the bulge is the approximate location of the liver cancer after the modeling is successful. The puncture site was gently pressed with cotton gauze for 15 seconds to prevent bleeding. After the wound stopped bleeding, the wound was sutured layer by layer, and penicillin and dexamethasone were injected intramuscularly for 3 consecutive days to prevent the animal from infection.

[0158] 2.2 Grouping and Dosing

[0159] After the 12 SD rats were successfully modeled, they were divided into 4 groups according to body weight using a random block design method, with 3 rats in each group, namely Example 8 group, radioactive comparative example 1 group, radioactive comparative example 2 group, and radioactive comparative example 6 group.

[0160] Rats in each group were anesthetized by intraperitoneal injection of ketamine, followed by mid-abdominal incision to separate the hepatic artery and gastroduodenal branch. A temporary sling was placed around the hepatic artery proximal to the gastroduodenal branch to prevent reflux. After ligation of the distal end of the gastroduodenal branch, the artery was cannulated with a thin polyethylene tube, fixed with a thin silk tie and connected to a syringe. Radioactive microspheres (1.2 mCi / kg) were injected, and the cannula was flushed with 0.2 mL of saline and removed. The proximal end of the gastroduodenal branch was then ligated, the bandage around the hepatic artery was removed, and the hepatic artery circulation was restored.

[0161] 2.3 Organizational Distribution

[0162] Rats were killed after 24 hours, and samples of tumor, normal liver, lung, kidney, bone, spleen, urine, and blood were taken out and weighed. Each biological sample was transferred to a 20 ml centrifuge tube; nitric acid and H2O2 were added and mixed evenly; heated at 90°C for 3 hours; acetic acid was added, cooled to room temperature, and all samples were transferred to a 20 ml liquid scintillation bottle. Radioactivity was measured using a liquid scintillation counter. Tissue concentrations were calculated and expressed as a percentage of injected dose per gram (% ID / g).

[0163] 3. Experimental results

[0164] The tissue distribution of each group is shown in Table 4.

[0165] Table 4

[0166]

[0167] As can be seen from Table 4, Example 8 is mainly distributed in tumor tissues, with less distribution in normal liver and lungs, T / N up to 8.32, and lung shunt of 9.27%, while radioactive comparative examples 1, 2, and 6 are also distributed in the liver and lungs, with T / N of about 4 and lung shunt of 18.8% to 23.14%. Therefore, the study shows that the density of the resin microspheres can be controlled at 1.05 to 1.35 g / cm by using the method provided by the present invention. 3 The particle size is controlled within the range of 20 to 40 μm, which can increase the enrichment of microspheres in tumors, improve the target-to-substance ratio, reduce pulmonary shunt and thus improve safety.

[0168] The specific implementation methods described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above description is only a specific implementation method of the present invention and is not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.

Claims

1. A method for preparing low-density resin microspheres for human body implantation, characterized in that: The resin microspheres include sodium polystyrene sulfonate resin microspheres, which are obtained by using a dispersant, styrene, divinylbenzene and an initiator to undergo a polymerization reaction, and then sequentially undergo purification, sulfonation, swelling and acid-base conversion to obtain the sodium polystyrene sulfonate resin microspheres; wherein the reaction temperature during the sulfonation and swelling process is lower than 65°C.

2. The method for preparing low-density resin microspheres for human body implantation according to claim 1, characterized in that: The preparation method of the sodium polystyrene sulfonate resin microspheres comprises the following steps: Dispersant pretreatment: dissolving the dispersant in water to obtain an initial dispersant solution; Polymerization reaction: After the dispersant solution is heated to a stable temperature, styrene, divinylbenzene and an initiator are added, and the mixture is heated to react under stirring, and then the temperature is raised again. After the reaction is completed, the mixture is immersed in pure water for sedimentation, and then washed to obtain polystyrene resin microspheres; Purification process: using a cleaning agent to clean the polystyrene resin microspheres, and drying after cleaning to obtain purified polystyrene resin microspheres; Sulfonation reaction: adding a sulfonating agent to the purified polystyrene resin microspheres, stirring and reacting, to obtain sulfonated polystyrene resin microspheres; Swelling process: adding a swelling agent to the sulfonated polystyrene resin microspheres, stirring the reaction and then standing, and then heating and swelling, increasing the temperature and swelling again in sequence; Acid-base conversion process: add sodium hydroxide solution to the sulfonated polystyrene resin microspheres obtained after swelling, filter after soaking, then wash with water until neutral, then transfer to hydrochloric acid solution for soaking, then filter again, and wash with water until neutral; repeat the above operation; then add sodium hydroxide solution to the sulfonated polystyrene resin microspheres, soak, filter and wash with water until neutral to obtain sodium polystyrene sulfonate resin microspheres.

3. The method for preparing low-density resin microspheres for human body implantation according to claim 2, characterized in that: The dispersant includes any one or more combinations of hydroxyethyl cellulose, polyvinyl alcohol, methyl cellulose, sodium dodecylbenzene sulfonate, and polypropylene alcohol.

4. The method for preparing low-density resin microspheres for human body implantation according to claim 2, characterized in that: The initiator includes any one or more combinations of azobisisobutyronitrile, methyl ethyl ketone peroxide, benzoyl peroxide, and cumene peroxide.

5. The method for preparing low-density resin microspheres for human body implantation according to claim 2, characterized in that: During the polymerization reaction, first heat to 25°C to 55°C, and then raise the temperature to 85°C to 95°C.

6. The method for preparing low-density resin microspheres for human body implantation according to claim 2, characterized in that: In the swelling reaction, the temperature for heating and swelling is 25°C to 50°C, the temperature for increasing the temperature and swelling is 55°C to 60°C, and the temperature for further increasing the temperature and swelling is 60°C to 65°C.

7. A low-density resin microsphere for human body implantation, characterized in that: The resin microspheres are prepared by the preparation method according to any one of claims 1 to 6 and have a density of 1.05 to 1.35 g / cm 3 of resin microspheres.

8. Use of resin microspheres prepared by the preparation method according to any one of claims 1 to 6, characterized in that: Included for radionuclide labeling.

9. The use of resin microspheres according to claim 8, characterized in that: The labeling method is as follows: the radionuclide labeling solution with determined activity and the sodium polystyrene sulfonate resin microspheres are stirred evenly, loaded for reaction, and washed to obtain the radioactively labeled resin microspheres.

10. The use of resin microspheres according to claim 9, characterized in that: The temperature of the loading reaction is 25°C to 50°C.